Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05143996
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-10-26
Brief Title:
CLN-049 in Patients With RelapsedRefractory Acute Myeloid Leukemia AML or Myelodysplastic Syndrome MDS
Sponsor:
Cullinan Therapeutics Inc
Organization:
Cullinan Therapeutics Inc
Organization Data
Organization:
Cullinan Therapeutics Inc
Class:
INDUSTRY
Study ID:
CLN-049-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cullinan Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None